ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Baseimmune Ltd

Baseimmune Ltd is an active company incorporated on 30 October 2019 with the registered office located in London, Greater London. Baseimmune Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12289125
Private limited company
Age
5 years
Incorporated 30 October 2019
Size
Unreported
Confirmation
Submitted
Dated 29 October 2024 (10 months ago)
Next confirmation dated 29 October 2025
Due by 12 November 2025 (2 months remaining)
Last change occurred 10 months ago
Accounts
Submitted
For period 1 Nov31 Oct 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Contact
Address
The London Bioscience Innovation Centre
Royal College Street
London
NW1 0NH
England
Address changed on 13 May 2022 (3 years ago)
Previous address was 71-75 Shelton Street London WC2H 9JQ England
Telephone
Unreported
Email
Unreported
People
Officers
6
Shareholders
24
Controllers (PSC)
1
Director • British • Lives in England • Born in Jun 1991
Director • Venture Capitalist • American • Lives in England • Born in Oct 1976
Director • Brazilian • Lives in England • Born in Feb 1991
Director • Venture Capital • British • Lives in England • Born in May 1988
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Apperio Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Skin Analytics Ltd
Hussein Kanji is a mutual person.
Active
Coolgarif Technologies Ltd
Hussein Kanji is a mutual person.
Active
Project J Ltd
Hussein Kanji is a mutual person.
Active
BMLL Technologies Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Ai Build Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Paragraf Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Risilience Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Brands
Baseimmune
Baseimmune is a discovery stage biotech company focused on antigen discovery and vaccine development.
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Oct 2024
For period 31 Oct31 Oct 2024
Traded for 12 months
Cash in Bank
£8.67M
Increased by £6.91M (+393%)
Turnover
Unreported
Same as previous period
Employees
17
Increased by 6 (+55%)
Total Assets
£9.69M
Increased by £7.26M (+299%)
Total Liabilities
-£66K
Decreased by £341.97K (-84%)
Net Assets
£9.62M
Increased by £7.6M (+376%)
Debt Ratio (%)
1%
Decreased by 16.12% (-96%)
Latest Activity
Notification of PSC Statement
10 Days Ago on 27 Aug 2025
Full Accounts Submitted
1 Month Ago on 29 Jul 2025
Accounting Period Extended
9 Months Ago on 13 Nov 2024
Confirmation Submitted
10 Months Ago on 5 Nov 2024
Full Accounts Submitted
1 Year 1 Month Ago on 17 Jul 2024
Iq Capital Directors Nominees Ltd Appointed
1 Year 8 Months Ago on 5 Jan 2024
Confirmation Submitted
1 Year 10 Months Ago on 2 Nov 2023
Philip James Gordon Kemlo (PSC) Resigned
4 Years Ago on 17 Mar 2021
Ariane Karla Cruz Gomes (PSC) Resigned
4 Years Ago on 17 Mar 2021
Joshua Miles Blight (PSC) Resigned
4 Years Ago on 17 Mar 2021
Get Credit Report
Discover Baseimmune Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Cessation of Ariane Karla Cruz Gomes as a person with significant control on 17 March 2021
Submitted on 27 Aug 2025
Cessation of Joshua Miles Blight as a person with significant control on 17 March 2021
Submitted on 27 Aug 2025
Cessation of Philip James Gordon Kemlo as a person with significant control on 17 March 2021
Submitted on 27 Aug 2025
Notification of a person with significant control statement
Submitted on 27 Aug 2025
Resolutions
Submitted on 27 Aug 2025
Total exemption full accounts made up to 31 October 2024
Submitted on 29 Jul 2025
Statement of capital following an allotment of shares on 6 December 2024
Submitted on 6 Dec 2024
Current accounting period extended from 31 October 2025 to 31 December 2025
Submitted on 13 Nov 2024
Confirmation statement made on 29 October 2024 with updates
Submitted on 5 Nov 2024
Second filing of a statement of capital following an allotment of shares on 8 January 2024
Submitted on 4 Nov 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year